The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Hearing-Related Quality of Life
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
The study will assess the effect of cancer treatments on speech perception in noise, cognition, and hearing-related quality of life by monitoring 200 cancer patients receiving standard care for their underlying malignancy.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: t
View:
• written informed consent
• native Finnish speaker
• age-normative hearing
• for participants in the treatment arms: diagnosis of a malignancy that will be treated with curative intent with any of the following: 1) Cisplatin as the main chemotherapeutic agent, 2) oxaliplatin as the main chemotherapeutic agent, 3) cisplatin-based chemoradiation therapy in the head and neck region, 4) radiation therapy in the head and neck region
Locations
Other Locations
Finland
Turku University Hospital
RECRUITING
Turku
Contact Information
Primary
Tytti Willberg, PhD
tytti.willberg@varha.fi
+358 2 313 5979
Time Frame
Start Date: 2024-10-02
Estimated Completion Date: 2030-12-31
Participants
Target number of participants: 250
Treatments
Cisplatin
50 patients receiving cisplatin as the standard care for their underlying malignancy
Cisplatin-based chemoradion therapy in the head and neck region
50 patients receiving cisplatin-based chemoradiation therapy in the head and neck region as the standard care for their underlying malignancy
Head and neck region radiation therapy
50 patient receiving head and neck region radiation therapy as the standard care for their underlying malignancy
Oxaliplatin
50 patients receiving oxaliplatin as the standard care for their underlying malignancy
Control
50 healthy volunteers who have never received any ototoxic medications
Related Therapeutic Areas
Sponsors
Leads: Turku University Hospital